Try digitalPLUS for 10 days for only $0.99

Hospira, Inc.

FDA takes steps increase supply of cancer drugs

A host of prescription drugs have been in low supply around the United States for some time, but doctors have been warning about a particularly acute shortage of a set of life-saving cancer drugs. Now the U.S. Food and Drug Administration said today that it has taken steps to boost the supply of those cancer drugs -- Doxil, or doxorubicin hydrochloride liposome injection, and methotrexate. On Doxil, the FDA plans to import temporarily a replacement drug called Lipodox to meet patient needs in coming weeks. On methotrexate, the agency expedited review of the application from the manufacturer APP Pharmaceuticals to make the necessary preservative-free drug here. Another maker, Hospira,...